KITLG (KIT Ligand) Gene

A key regulator of hematopoiesis, melanogenesis, and germ cell development, with implications in cancer and pigmentation disorders.

Gene Information Card

Symbol KITLG
Full Name KIT ligand
Gene Type protein-coding
Chromosomal Location 12q21.32
NCBI Gene ID 4254 ncbi.nlm.nih.gov/gene/4254
Ensembl ID ENSG00000049130
UniProt ID P21583
OMIM ID 184745
HGNC ID 6343
Aliases SCF, MGF, SF, KL-1, Kitl, FPH2, SHEP7

Description

The KITLG gene encodes the KIT ligand (also known as stem cell factor, SCF), a cytokine that binds to the KIT receptor (CD117). This interaction is critical for the survival, proliferation, and differentiation of hematopoietic stem cells, melanocytes, and germ cells. Alternative splicing produces soluble and membrane-bound isoforms, which differentially regulate KIT signaling. Mutations in KITLG are associated with pigmentation disorders, hematologic malignancies, and germ cell tumors.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Piebaldism Loss-of-function mutations in KITLG reduce melanocyte migration/survival, leading to depigmented patches. OMIM #172800
Acute Myeloid Leukemia (AML) KITLG overexpression or autocrine signaling promotes leukemic cell proliferation via KIT activation. COSMIC; PubMed studies
Germ Cell Tumors (e.g., seminoma) Gain-of-function mutations or amplification of KITLG activate KIT signaling, driving tumorigenesis. COSMIC; OMIM #273300
Mastocytosis KITLG-KIT signaling dysregulation contributes to mast cell hyperplasia. ClinVar; literature review

Expression Profile

Tissue Expression
Tissue nTPM level
Bone Marrow 12.5 High
Skin 8.2 Medium
Testis 15.1 High
Small Intestine 6.8 Medium
Liver 2.3 Low
Cell Line Expression
Cell Line nTPM Notes
K562 (leukemia) 18.4 High expression; autocrine loop
A549 (lung) 5.1 Moderate expression
HEK293 (embryonic kidney) 3.2 Low expression
HCT116 (colon) 4.7 Moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.52G>A (p.Ala18Thr) Missense <0.1% Unknown; rare variant in population databases
c.107T>C (p.Leu36Pro) Missense <0.1% Associated with piebaldism; loss of function
c.1A>G (p.Met1?) Start loss <0.1% Likely loss of function; reported in AML
Amplification Copy number gain ~5% in seminoma Gain of function; increased KITLG expression
Mutation functional classification

Loss of Function (LOF)

Missense or nonsense mutations (e.g., p.Leu36Pro) impair KITLG binding to KIT, reducing melanocyte development and causing piebaldism.

Gain of Function (GOF)

Amplification or overexpression of KITLG in germ cell tumors leads to constitutive KIT signaling, promoting cell proliferation.

Dominant Negative (DN)

Not well documented for KITLG; most mutations are recessive or haploinsufficient.

Pathways

KITLG-KIT signaling pathway (Reactome: R-HSA-1433557)
PI3K/AKT signaling (Reactome: R-HSA-1257604)
MAPK/ERK signaling (Reactome: R-HSA-5673001)
Hematopoietic cell lineage (KEGG: hsa04640)
Melanogenesis (KEGG: hsa04916)

Protein Summary

The KIT ligand (SCF) is a 245-amino acid glycoprotein that exists as a membrane-bound or soluble form. It binds as a dimer to the KIT receptor tyrosine kinase, inducing receptor dimerization and autophosphorylation. This activates downstream pathways including PI3K/AKT, MAPK/ERK, and STAT, regulating cell survival, proliferation, and migration. The protein is essential for hematopoiesis, melanogenesis, and gametogenesis.

Related Products

Product name Cat.No. Species Gene ID
KITLG Knockout HEK293 Cell Line EDJ-KQ680 Human 4254 Details Get a Quote
KITLG Knockout A-549 Cell Line EDJ-KQ19221 Human 4254 Details Get a Quote
KITLG Knockout HCT 116 Cell Line EDJ-KQ19222 Human 4254 Details Get a Quote
KITLG Knockout HeLa Cell Line EDJ-KQ19223 Human 4254 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: